Synthetic biology: the pathway to commercialisation

July 26, 2016 8:30 - 9:45 am


The emerging science of synthetic biology (SynBio) has the potential to transform the industrial landscape in sustainable manufacturing processes across industrial sectors, such as healthcare, sustainable energy, green chemistry, pharmaceuticals, novel materials and bioremediation, and to address major societal grand challenges.

However, the effective commercialisation will require us to address a number of challenges including a properly trained workforce, changes to manufacturing, appropriate legal and governance frameworks, physical infrastructure, understanding and mitigation of risks, and SOPs for safe working with the GM organisms. Public acceptance and endorsement of SynBio products is essential in their commercial viability together with an understanding and early consideration of the societal impact of the changes to processes. Commercial exploitation of SynBio applications will thus require confluence of new enabling tools and clear understanding of the current state and readiness of the science and industry. This panel debate will discuss these challenges in an open forum.

the speakers

There is no speaker associated to this event

Go back